Pandorum Technologies receives BIRAC grant to develops artificial tissues that perform functions of human liver
New Delhi: A Bengaluru-based biotechnology start-up has developed a 3D-printed tissue that functions like a human liver and can one day be used for full-fledged liver transplants, according to the developers.These 3D printed living tissues enable affordable medical research with reduced animal and human trials, and will eventually lead to full scale transplantable organs. The company is supported by grants from the Biotechnology Industry Research Assistance Council (BIRAC), government of India, and is located in the Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru Bio-Cluster.
The tissues, made of human cells, would allow for inexpensive medical research with decreased reliance on animal and human trials, and could eventually be used for liver transplants, according to Pandorum Technologies - the company that developed the tissue.
"Our 3D bio-printed mini-livers that mimic the human liver will serve as test platforms for discovery and development of drugs with better efficacy, less side effects and at lower costs," Pandorum co-founder Arun Chandru was reported as saying by ibtimes.com.
The artificial liver tissues not only represent a major step towards on-demand manufacturing of human organs for transplant, but also have potential to be a game changer for developing new medicines and vaccines.
Usually, it requires millions of dollars spent over several years for a single new drug to come to the market.Pharma giants on an average spend over US$10 billion for R&D to get a single new drug to market with the approval USFDA approval. The global market for in vitro toxicity testing alone is expected to reach US$ 4 billion by 2018
Bhowmick Said that "in the near future, such artificial organs will address the acute shortage of human organs available for surgical transplantation".
To know more about the latest update on this treatment protocol and treating centers offering the same as well as
for getting your reports reviewed, post a query
